Physician profile
Robert D Shutt
NPI 1740388693
$620.41
in general payments reported to CMS, 2019-2025
17 companies · $27.33 in 2025
The $27.33 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $70.70 · 2021: $102 · 2022: $18.07 · 2023: $60.01 · 2024: $61.64 · 2025: $27.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $171.41 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $82.42 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $56.35 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.41 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $38.02 | 2019-2020 | |
| Valeritas, INC. | $32.23 | 2019 | |
| Lilly USA, LLC | $28.43 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $27.83 | 2020-2021 | |
| Abbvie INC. | $18.17 | 2024 | |
| Sanofi-Aventis U.S. LLC | $17.59 | 2019 | |
| Dexcom, INC. | $17.47 | 2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $16.81 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.71 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.33 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.62 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.68 | 2019 | |
| Zyla Life Sciences, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Shutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.